A protective effect of GLP-1 agonists on blood vessels has been demonstrated, as evidenced by the reduction of non-fatal and fatal stroke incidence by 15% and 19%, respectively, in patients with T2DM treated with GLP-1 agonists [43]
In a systematic review and meta-analysis published in the Journal of Infection, investigators used the PubMed, EMBASE, Cochrane Library and Web of Science databases to identify 136 randomized controlled trials reporting on infections among patients receiving GLP-1 receptor agonists or placebo
10.3855/jidc.6842 Mustafa AM, Abouelenein D, Acquaticci L, et al.: Polyphenols, Saponins and Phytosterols in Lentils and Their Health Benefits: An Overview
Credit: Kathy Wong for Endpoints News The FDA ad crackdown has pharma's attention
This morning delivered first-quarter financial reports from Pfizer , Regeneron , AstraZeneca , Novartis, Incyte, and Verona Pharma